Causal Effects of COVID-19 on the Risk of Thrombosis: A Two-Sample Mendel Randomization Study

Zhengran Li1,2, Minghui Zeng3, Tong Wu4

  • 1The Second Clinical Medicine School, Southern Medical University, Guangzhou, Guangdong, China.

PubMed

Insights

This study reveals how COVID-19 impacts thrombosis biomarkers. Lowering tissue factor pathway inhibitor (TFPI) and interleukin-1 receptor type 1 (IL-1R1) suggests a causal link between COVID-19 and increased thrombosis risk.

Area of Science:

  • Biomedical Science
  • Genetics
  • Epidemiology

Background:

  • The link between Coronavirus disease 2019 (COVID-19) and thrombosis is established, yet the underlying biomolecular mechanisms remain largely unknown.
  • Investigating the causal relationship between COVID-19 and thrombotic biomarkers is crucial for understanding disease pathogenesis and developing targeted therapies.

Purpose of the Study:

  • To investigate the causal relationship between COVID-19 and 20 key thrombotic biomarkers using Mendelian randomization.
  • To elucidate the biomolecular mechanisms linking COVID-19 infection to thrombotic events.

Main Methods:

  • Two-sample Mendelian randomization (MR) was employed to assess the effect of COVID-19 on thrombotic biomarkers.
  • Causality was estimated using inverse variance weighting, with sensitivity analyses performed using weighted median, MR-Egger regression, and MR-PRESSO methods.
  • Results were corrected for multiple testing using the false discovery rate (FDR) with the Benjamin and Hochberg method.

Main Results:

  • COVID-19 was associated with significantly lower levels of tissue factor pathway inhibitor (TFPI) and interleukin-1 receptor type 1 (IL-1R1), nearly doubling the odds of thrombosis.
  • Hospitalized cases showed reduced levels of plasminogen activator, tissue type (tPA) and P-selectin glycoprotein ligand 1 (PSGL-1), while severe cases exhibited higher mean platelet volume (MPV) and lower platelet count.
  • These biomarker changes, particularly in TFPI, tPA, IL-1R1, MPV, and platelet count, suggest an elevated risk of thrombosis in COVID-19 patients.

Conclusions:

  • TFPI, IL-1R1, and seven other indicators provide causal insights into the pathogenesis of COVID-19 and thrombosis.
  • This study provides robust evidence that COVID-19 causally influences thrombosis at the biomolecular level.
  • Findings highlight potential therapeutic targets for managing thrombotic complications in COVID-19.
Abstract

Related Concept Videos

Causality in Epidemiology01:21

Causality in Epidemiology

Causality or causation is a fundamental concept in epidemiology, vital for understanding the relationships between various factors and health outcomes. Despite its importance, there's no single, universally accepted definition of causality within the discipline. Drawing from a systematic review, causality in epidemiology encompasses several definitions, including production, necessary and sufficient, sufficient-component, counterfactual, and probabilistic models. Each has its strengths and...
416
Criteria for Causality: Bradford Hill Criteria - II01:28

Criteria for Causality: Bradford Hill Criteria - II

The Bradford Hill criteria serve as guidelines for establishing causative links in epidemiological research. Beyond Strength, Consistency, Specificity, and Temporality, key criteria also include Biological Gradient, Plausibility, Coherence, Experiment, and Analogy. These principles assist scientists in assessing the likelihood of causation in complex biological contexts. Below is a summary of these concepts:
318
Study Designs in Epidemiology01:20

Study Designs in Epidemiology

Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
218
Randomized Experiments01:13

Randomized Experiments

The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
6.9K
Regression Toward the Mean01:52

Regression Toward the Mean

Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when...
6.3K
Confounding in Epidemiological Studies01:27

Confounding in Epidemiological Studies

Confounding in statistical epidemiology represents a pivotal challenge, referring to the distortion in the perceived relationship between an exposure and an outcome due to the presence of a third variable, known as a confounder. This variable is associated with both the exposure and the outcome but is not a direct link in their causal chain. Its presence can lead to erroneous interpretations of the exposure's effect, either exaggerating or underestimating the true association. This...
170